Infectious Complications from High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Germ Cell Tumors

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 5, 2008, Pages 595-600

  Jathavedam, Ashwin ^a   Feldman, Darren R ^a   Ishill, Nicole ^a   Turkula, Stefan ^a   Patil, Sujata ^a   Bosl, George J ^a   Motzer, Robert J ^a   Weinstock, David M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Autologous; Germ cell tumor; High dose chemotherapy; Infection; Infectious complications; Transplant

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; CARBOPLATIN; CIPROFLOXACIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; IVERMECTIN; LEVOFLOXACIN; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VORICONAZOLE;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTEREMIA; BACTERIAL PNEUMONIA; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CATHETER INFECTION; CELLULITIS; CHICKENPOX; COLITIS; CONTROLLED STUDY; DEATH; DRUG FEVER; DRUG MEGADOSE; DRUG WITHDRAWAL; ENTERITIS; ESOPHAGUS CANDIDIASIS; EXTERNAL OTITIS; FEMALE; GERM CELL TUMOR; HERPES SIMPLEX; HERPES ZOSTER; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTIOUS COMPLICATION; INFLUENZA; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MULTIPLE CYCLE TREATMENT; MYCOSIS; NEUTROPENIA; NEUTROPENIC ENTEROCOLITIS; NON SEMINOMATOUS GERMINOMA; OTITIS MEDIA; PERITONSILLAR ABSCESS; PHARYNGITIS; RETROSPECTIVE STUDY; SEMINOMA; SKIN ABSCESS; STRONGYLOIDIASIS; TOOTH ABSCESS; UNITED STATES; URINARY TRACT INFECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IFOSFAMIDE; INFECTION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PACLITAXEL; PREMEDICATION; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 41849136892     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.02.020     Document Type: Article

References (21)

1. Bajorin D.F., Sarosdy M.F., Pfister D.G., et al. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol 11 (1993) 598-606
2. Williams S.D., Birch R., Einhorn L.H., Irwin L., Greco F.A., and Loehrer P.J. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316 (1987) 1435-1440
3. Kondagunta G.V., and Motzer R.J. Chemotherapy for advanced germ cell tumors. J Clin Oncol 24 (2006) 5493-5502
4. Kondagunta G.V., Bacik J., Sheinfeld J., et al. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. J Clin Oncol 25 (2007) 85-90
5. Einhorn L.H., Williams S.D., Chamness A., Brames M.J., Perkins S.M., and Abonour R. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 357 (2007) 340-348
6. Daugaard G., Nielsen H., Bruun B., Hansen F., Geertsen P., and Schonheyder H. Infections in patients treated with high-dose chemotherapy for germ cell tumours. Eur J Cancer 29A (1993) 2220-2222
7. Prevention and Treatment of Cancer-Related Infections. NCCN Clinical Practice Guidelines in Oncology (2007) 1-96
8. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 49 (2000) 1-125 CE1-7
9. Motzer R.J., Mazumdar M., Sheinfeld J., et al. Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol 18 (2000) 1173-1180
10. Ascioglu S., Rex J.H., de Pauw B., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7-14
11. Kruger W., Russmann B., Kroger N., et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation-a 7 year single centre investigation of 409 cases. Bone Marrow Transplant 23 (1999) 589-597
12. Morgan J., Wannemuehler K.A., Marr K.A., et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 43 Suppl 1 (2005) S49-S58
13. Nosanchuk J.D., Sepkowitz K.A., Pearse R.N., White M.H., Nimer S.D., and Armstrong D. Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 18 (1996) 355-359
14. Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multi-institutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353 (2005) 2442-2449
15. Bilgrami S., Chakraborty N.G., Rodriguez-Pinero F., et al. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue. Bone Marrow Transplant 23 (1999) 469-474
16. Zambelli A., Montagna D., Da Prada G.A., et al. Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients. Anticancer Res 22 (2002) 3701-3708
17. Cullen M., Steven N., Billingham L., et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353 (2005) 988-998
18. Bucaneve G., Micozzi A., Menichetti F., et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353 (2005) 977-987
19. Gafter-Gvili A., Fraser A., Paul M., and Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 142 (2005) 979-995
20. von Baum H., Sigge A., Bommer M., et al. Moxifloxacin prophylaxis in neutropenic patients. J Antimicrob Chemother 58 (2006) 891-894
21. Bilgrami S., Feingold J.M., Dorsky D., et al. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23 (1999) 1039-1042